Free Trial

Rhumbline Advisers Has $17.50 Million Stock Holdings in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Rhumbline Advisers cut its holdings in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 1.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,035,549 shares of the real estate investment trust's stock after selling 18,505 shares during the quarter. Rhumbline Advisers owned about 0.29% of Healthcare Realty Trust worth $17,501,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Blue Trust Inc. boosted its position in Healthcare Realty Trust by 130.3% during the 4th quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust's stock worth $30,000 after acquiring an additional 925 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in Healthcare Realty Trust by 59.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 612 shares during the last quarter. Synergy Investment Management LLC acquired a new position in Healthcare Realty Trust during the 4th quarter worth approximately $36,000. Lazard Asset Management LLC acquired a new position in Healthcare Realty Trust during the 4th quarter worth approximately $45,000. Finally, Jones Financial Companies Lllp boosted its position in Healthcare Realty Trust by 68.7% during the 4th quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust's stock worth $52,000 after acquiring an additional 1,249 shares during the last quarter.

Healthcare Realty Trust Trading Up 1.9%

HR opened at $14.46 on Friday. Healthcare Realty Trust Incorporated has a 1-year low of $14.09 and a 1-year high of $18.90. The stock's fifty day simple moving average is $15.19 and its 200 day simple moving average is $16.31. The stock has a market cap of $5.08 billion, a PE ratio of -8.12 and a beta of 0.88.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The business had revenue of $288.86 million for the quarter, compared to analysts' expectations of $297.39 million. During the same quarter in the prior year, the business earned $0.39 EPS. The firm's revenue for the quarter was down 9.2% on a year-over-year basis. Equities analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 23rd. Shareholders of record on Monday, May 12th were issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 8.58%. The ex-dividend date was Monday, May 12th. Healthcare Realty Trust's dividend payout ratio is -113.76%.

Insider Buying and Selling at Healthcare Realty Trust

In other news, Director Thomas N. Bohjalian acquired 2,500 shares of the firm's stock in a transaction on Tuesday, May 13th. The shares were purchased at an average cost of $14.71 per share, with a total value of $36,775.00. Following the acquisition, the director now directly owns 56,502 shares in the company, valued at $831,144.42. This represents a 4.63% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.37% of the company's stock.

Analyst Upgrades and Downgrades

HR has been the subject of a number of recent research reports. Scotiabank reduced their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a research report on Tuesday, February 25th. Wall Street Zen cut Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Saturday, May 31st. Wedbush dropped their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Finally, Wells Fargo & Company dropped their price objective on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a research note on Monday, June 2nd. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $16.80.

View Our Latest Analysis on Healthcare Realty Trust

Healthcare Realty Trust Company Profile

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Featured Stories

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines